HAS Achieves Top Sustainability Score from CDP
Biasca, February 18, 2025 – HAS is proud to announce that it has received a B SME score from the CDP (formerly Carbon Disclosure Project) for its outstanding climate strategy and concrete actions to combat climate change. This prestigious recognition is the highest score awarded to small and medium-sized enterprises (SMEs) that publicly disclose their environmental information through the CDP questionnaire.
What is CDP?
The CDP is an international non-profit organization that collects and evaluates environmental data from companies, cities, and regions worldwide. Its mission is to promote transparency and environmental action, helping organizations understand and manage their environmental impact. As of today, with over 22,000 companies disclosing their environmental information through CDP, it is one of the most authoritative platforms for environmental impact management ratings.
Importance of the B SME Score
Receiving a B SME score in the "Climate Change" category signifies that HAS's climate strategy aligns with global best practices for SMEs and contributes effectively to combating climate change. This score reflects HAS's commitment to environmental transparency, understanding of climate-related risks and opportunities, strategic emission reduction, and efficient environmental performance monitoring.
Key Highlights:
- Transparency and Reputation: Enhances HAS's reputation among clients and stakeholders by demonstrating a strong commitment to environmental transparency.
- Understanding Risks and Opportunities: Shows a comprehensive understanding of climate-related risks and opportunities.
- Strategic Emission Reduction: Confirms that our strategic plan to reduce greenhouse gas emissions is effective and aligned with global best practices in the industry.
Ongoing Commitment
This B SME score represents a significant milestone in HAS's sustainability program. The company remains committed to continuously improving its environmental practices and achieving new milestones. HAS acknowledges the crucial role of its clients and stakeholders in this journey and expresses gratitude for their ongoing support and dedication.
About HAS Healthcare Advanced Synthesis
HAS Healthcare Advanced Synthesis, a CDMO with four decades of experience and excellence, offers a full range of customized services from laboratory development to manufacturing. HAS Healthcare Advanced Synthesis develops and produces active pharmaceutical ingredients (APIs), advanced intermediates, high-activity active pharmaceutical ingredients (HPAPIs) and anticancer compounds.
The production facility is located in Biasca, Switzerland, and was founded in 1984. The site is regularly inspected by SwissMedic, FDA and other global regulatory Agencies. The production scale ranges from a few hundred grams to tens of kilograms for highly active ingredients (HPAPI) and anticancer and from kilograms to tens of tons for standard active ingredients (APIs); the plants are completely dedicated to cGMP production.
For more information visit our website https://www.hashealthcare.com/ and follow us on Linkedin.
Contact Press Office
HAS Healthcare Advanced Synthesis
Biasca, Switzerland
Giacomo Braglia
Tel: +41 (0) 91 873 94 00
Email: [email protected]